NCT00057980: Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma |
|
|
| Completed | 1/2 | 8 | US | celecoxib, epirubicin hydrochloride | Northwestern University, National Cancer Institute (NCI) | Liver Cancer | 02/07 | 02/07 | | |
NCT00293436: Celecoxib and Erlotinib in Treating Patients With Liver Cancer |
|
|
| Withdrawn | 1/2 | 0 | US | celecoxib, erlotinib hydrochloride, adjuvant therapy | University of California, San Francisco, National Cancer Institute (NCI) | Liver Cancer | | | | |
